[Vaccines for the treatment of non-small cell lung cancer].
Fiche publication
Date publication
mars 2019
Journal
Revue des maladies respiratoires
Auteurs
Lien Pubmed
Résumé
Antigen-specific immunotherapy also known as cancer vaccination offers a novel approach for the treatment of non-small cell lung cancer patients. It relies on specific priming of the immune system in order to provoke or increase adaptive antitumor immune response against the vaccine component. Several molecules have been developed in lung cancer, based on whole-tumor cells, dendritic cells, peptides, recombinant proteins, or viral vectors. The aim of this review is to describe the mechanism of action of these vaccines and the results of the main clinical studies.
Référence
Rev Mal Respir. 2019 Mar 19;: